Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page
- ChecktodayChange DetectedThe page now includes a 'No longer looking for participants' notice indicating the study is not recruiting, and adds new sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' to assist users. The header 'Intervention/Treatment' is standardized and the revision tag updates from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check7 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5, indicating a newer build or revision tag rather than a substantive content change.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating a new release of the page content. No visible content or functionality changes are indicated by this update.SummaryDifference0.0%

- Check51 days agoChange DetectedLocation entries for Chile are updated to use shorter regional labels (e.g., “Araucania” and “Valparaiso”) alongside the same city and site details. The page footer revision version is also incremented from v3.5.0 to v3.5.3.SummaryDifference0.4%

- Check86 days agoChange DetectedRevision label updated to v3.5.0. The previous label v3.4.3 was removed.SummaryDifference0.0%

- Check101 days agoChange Detected- Added Revision: v3.4.3 - Deleted Revision: v3.4.2SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.